Cargando…
ELF1 suppresses autophagy to reduce cisplatin resistance via the miR‐152‐3p/NCAM1/ERK axis in lung cancer cells
Resistance to chemotherapeutic drugs limits the efficacy of chemotherapy in non–small cell lung cancer (NSCLC). Autophagy is an essential mechanism which involves in drug resistance. Our previous research has revealed that miR‐152‐3p represses NSCLC progression. However, the mechanism of miR‐152‐3p...
Autores principales: | Zhao, Lifeng, Wu, Xiangsheng, Zhang, Zhiwen, Fang, Lini, Yang, Bo, Li, Yepeng |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10236622/ https://www.ncbi.nlm.nih.gov/pubmed/36846943 http://dx.doi.org/10.1111/cas.15770 |
Ejemplares similares
-
DNMT3B regulates proliferation of A549 cells through the microRNA-152-3p/NCAM1 pathway
por: Yang, Bo, et al.
Publicado: (2022) -
MicroRNA-152 suppresses cisplatin resistance in A549 cells
por: Zhao, Wenfei, et al.
Publicado: (2019) -
MicroRNA-152 suppresses cisplatin resistance in A549 cells
por: Zhao, Wenfei, et al.
Publicado: (2020) -
miR-98-5p contributes to cisplatin resistance in epithelial ovarian cancer by suppressing miR-152 biogenesis via targeting Dicer1
por: Wang, Yanan, et al.
Publicado: (2018) -
Effects of pharmacological treatments on hippocampal NCAM1 and ERK2 expression in epileptic rats with cognitive dysfunction
por: Kong, Qingxia, et al.
Publicado: (2016)